KapStone Reports Record Third Quarter Results

Stock Information for Lineage Cell Therapeutics, Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Lineage Cell Therapeutics, Inc.

WestRock Completes Acquisition of KapStone
Keysight Technologies Set to Join S&P 500; Ligand Pharmaceuticals to Join S&P MidCap 400; Marcus & Millichap and Arcosa to Join S&P SmallCap 600
U.S. Department of Justice Clears WestRock's Acquisition of KapStone
Recent Analysis Shows FMC, Sensient Technologies, Flowserve, Consolidated Edison, KapStone Paper and Packaging, and Antero Midstream Partners LP Market Influences - Renewed Outlook, Key Drivers of Growth
WestRock and KapStone Announce Preliminary Merger Consideration Election Results
KapStone Paper And Packaging Corporation Announces Cash Dividend
WestRock and KapStone Announce Anticipated Election Deadline of September 5, 2018
KapStone Reports Second Quarter Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.